Navigation Links
Dedication to the Medical Industry - The First International PEEK Meeting
Date:4/24/2013

Thornton-Cleveleys, UK (PRWEB) April 24, 2013

The First International PEEK Meeting will convene April 25-26 at The Union League in Philadelphia, PA. The conference provides a global forum to share leading edge research on advancements in medical grade PEEK technology and clinical applications.

Medical device designers, material scientists and clinicians specializing in biomaterials are expected to attend. Podium and poster presentations will cover a wide range of PEEK topics including: properties, test methods and processing; biocompatibility; wear properties; modifications that alter cellular reactions; biomechanical performance of devices; and clinical performance and retrieval studies of PEEK based implants.

The conference is a testament to the rate at which PEEK is becoming the preferred implant material across a growing number of medical applications. More than 35 abstracts that cover applications as diverse as posterior spinal rods, self-tapping suture anchors, joint replacement bearing surfaces and patient specific craniomaxilofacial implants were accepted for inclusion in the conference program.

This inaugural meeting is organized by the Implant Research Center at Drexel University and the engineering and scientific consulting firm Exponent and supported by Invibio® Biomaterial Solutions, the global leader of PEEK-based biomaterials to the medical device industry.

Invibio strives to advance medical device innovation through support of robust PEEK research and development programs. Invibio has been involved in many of the research projects that will be presented at the PEEK International Meeting, through collaborations with industry and academia. John Devine, the Marketing and Technology Director at Invibio comments, “Since its inception in 1999, Invibio has invested heavily in basic science and applied research related to high performance implantable polymers used in medical devi
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstanding Shares of Common Stock of Obagi Medical Products, Inc.
2. VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
3. Technical Workshops at OrthoTec 2013 Focus on Risk Management Throughout Medical Device Lifecycle and Robust Material Selection Process Development
4. AFcell Medical Hires Chief Operating Officer
5. OHK Medical Devices appoints Mr. Omer Inbar as Chief Executive Officer
6. Maryville, Tennessee Based Molecular Pathology Laboratory Network (MPLN) Celebrates 38th Annual Medical Laboratory Professional Week by Honoring Employees
7. Nebraska Medical Center Implants States First SynCardia Total Artificial Heart
8. Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
9. BioClinica Releases Integrated Medical Image Management Solution
10. Surefire Medical Launches Next Generation Infusion System ST-LT and Specialty Catheters at SIR - Maximizing Targeted Delivery of Embolics Without Reflux
11. AtheroNova Adds New Medical Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 In recent years, growing ... methods in product development and promotion has led to ... mistrust, fueled by concerns about the insidious impact of ... of spectacular fines to the world’s biggest pharmas for ...
(Date:1/14/2014)... 14, 2014 Global Record Systems, ... information technology solutions for patients, physicians, the biopharmaceutical ... announced today the signing of a three-year Research ... Drug Administration (FDA). This initiative is designed ...
(Date:1/14/2014)... USA, and Cardiff, UK (PRWEB) January 13, 2014 ... technology development leader with more than 20 years in ... for optics and photonics . Hainsey will serve as ... delighted to have Dr. Hainsey join SPIE as our ...
(Date:1/14/2014)... During the 1600’s through the 1800’s doctors contributed ... In this time period, doctors did not know that they ... the death of vulnerable patients. In the same way, medical ... be unwittingly transmitting herpes viruses to their patients. The CBCD ...
Breaking Biology Technology:The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3
... OSAKA, Japan, August 16 /PRNewswire-FirstCall/,-- Santhera Pharmaceuticals ... with a focus on neuromuscular diseases, and ... that the European Medicines Agency (EMEA) has ... (MAA) for Santhera,s lead compound,SNT-MC17 (INN: idebenone, ...
... Aug. 16 Cancer patients fraught with,flare-ups of ... assistance,in the form of a new easy-to-use oral ... quickly deliver pain medication. Cancer patients frequently ... cancer pain is characterized as continuous pain,present for ...
... 16 Advanced Life Sciences,Holdings, Inc. (Nasdaq: ... 2007 the,Nasdaq Listings Qualifications Department informed the Company ... below $50 million for 10,consecutive days, which is ... Market according to Marketplace Rule 4450(b)(1)(A). Nasdaq,also informed ...
Cached Biology Technology:European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera 2European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera 3European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera 4European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera 5European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera 6Novel Technology Breaks Through Cancer Pain 2Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter 2Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter 3Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter 4
(Date:4/17/2014)... developed at Sandia National Laboratories and recently licensed to ... cheaper. , Bacillus anthracis , the bacteria ... over the world and can cause serious, and often ... can survive in harsh conditions for decades. In humans, ... skin contact, inhalation of spores or eating contaminated meat. ...
(Date:4/17/2014)... about eight years ago, Katia Silvera , a postdoctoral ... were on a field trip in a mountainous area in ... never seen before. , Unable to identify it, they contacted ... turned out to be an unnamed species. So Carnevali recently ... "Lophiaris" is the genus name, comprising about 40 species in ...
(Date:4/17/2014)... a novel method to help kidney stone sufferers ... treatment possible., Kidney stones represent a major medical ... left untreated, apart from being particularly painful, they ... In many patients treated successfully, stone recurrence is ... approach to diagnosis and treatment needs to be ...
Breaking Biology News(10 mins):Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3Orchid named after UC Riverside researcher 2Orchid named after UC Riverside researcher 3
... As researchers continue to examine the role ... people understand the differences among various ingredients used ... Association (CRA). Interchanging two distinctly different ingredients, such ... creates factually incorrect conclusions and misleads ,consumers. ...
... 4, 2009 Ben-Gurion University of the Negev engineers ... large nuclear reactors, making it unsuitable for use in ... form of the basic synthetic element found in commercial ... used for peaceful purposes. , This technique could help ...
... and very large reductions in greenhouse gas emissions compared ... messages from a series of expert papers on "The ... a special issue of Biofuels, Bioproducts and Biorefining ... which includes a comparative analysis of more than a ...
Cached Biology News:Pure fructose frequently confused with high fructose corn syrup 2Ben-Gurion University engineers develop technique to help combat nuclear proliferation 2Cellulosic biofuel technology will generate low-cost green fuel, says major study 2Cellulosic biofuel technology will generate low-cost green fuel, says major study 3
anti-dansyl, rabbit IgG fraction *1 mg/mL* Secondary Detection; Anti-Dye and Anti-Hapten Antibodies...
MOUSE ANTI GUINEA PIG T-CELLS (PAN):FITC Immunogen: Guinea pig peritoneal T-cells...
... Error-free cloning of BAC (100+kb), fosmid ... Greater insert stability than any othe BAC ... for high yields and easy recombinant DNA ... or transcription-free (pSMART VC) vectors for the ...
... cloning of BAC (100+kb), fosmid (40kb), and ... stability than any othe BAC vector. On ... yields and easy recombinant DNA purification. Available ... (pSMART VC) vectors for the highest insert ...
Biology Products: